Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2024

MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements Totaling $7.3M

Posted on September 30, 2024 by MissionIR

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, has entered into a securities purchase agreement. The company entered the agreement, which calls for the issue and sale … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS), Staque Join Forces to Advance Annealing Quantum Computing Adoption in the Middle East

Posted on September 30, 2024 by MissionIR

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, announced a new strategic partnership with Staque, a leading consulting and development practice focused on AI, blockchain and quantum … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Begin Human Pilot Study #3 Evaluating DehydraTECH-Processed Tirzepatide

Posted on September 27, 2024 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Friday that it had received approval from an independent review board for its planned human pilot study #3. The approval signals that the company can begin the … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

SuperCom Ltd. (NASDAQ: SPCB) Makes New Inroads with Monitoring Technology Contract Win in NY

Posted on September 26, 2024 by MissionIR

As the market for electronic monitoring (“EM”) products and services grows within the public safety technology sector, EM technology innovator SuperCom (NASDAQ: SPCB) is experiencing increasing contract wins both in the U.S. and Europe. SuperCom’s latest new contract announcement involves … Continue reading →

Posted in SuperCom Ltd. SPCB | Leave a comment

SOBRsafe Inc. (NASDAQ: SOBR) Experiencing New Growth After Entering the Behavioral Health Market

Posted on September 25, 2024 by MissionIR

SOBRsafe (NASDAQ: SOBR), the developer of advanced transdermal alcohol detection and monitoring technology, has made substantial progress in 2024. The company has secured 35 new customer accounts this year, a substantial increase over 2023. The success followed the company’s late … Continue reading →

Posted in SOBRsafe Inc. SOBR | Leave a comment

Annovis Bio Inc. (NYSE: ANVS) Presented Recent Achievements and Strategic Direction at H.C. Wainwright Investment Conference

Posted on September 25, 2024 by MissionIR

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), participated in the H.C. Wainwright 26th Annual Global Investment Conference, held virtually, as well as … Continue reading →

Posted in Annovis Bio Inc. ANVS | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Shares Video Update from CEO

Posted on September 24, 2024 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today shared a video update to shareholders provided by CEO and Chairman David Michery. In the video, Michery provides a detailed overview of the company’s recent progress, including sales and … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology

Posted on September 24, 2024 by MissionIR

Nutriband (NASDAQ: NTRB), a pharmaceutical company with a special focus on transdermal technologies, is announcing that its patent application, which protects its AVERSA(TM) abuse deterrent transdermal technology, has been allowed in China. This follows the receipt of a Notice of … Continue reading →

Posted in Nutriband Inc. NTRB | Leave a comment

Clene Inc. (NASDAQ: CLNN) to Discuss Lead Candidate CNM-Au8(R) Biomarker, Clinical Data for ALS with Food and Drug Administration Leadership

Posted on September 24, 2024 by MissionIR

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), announced an upcoming … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Subsidiary Positioned in Lithium-Sulfur Battery Space

Posted on September 24, 2024 by MissionIR

The battery of choice these days, relied on to power everything from digital devices to electric vehicles and even energy-storage systems, is the lithium-ion battery. However, lithium-ion technology has its drawbacks; consequently, other battery solutions are being developed, including lithium … Continue reading →

Posted in Platinum Group Metals Ltd. PLG | Leave a comment